Home › Funds › RIVERBRIDGE PARTNERS LLC › WST

RIVERBRIDGE PARTNERS LLC position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

RIVERBRIDGE PARTNERS LLC reported holding 208,015 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q3 2026 13F filing — a position valued at US$77.1M, representing 2.26% of its reported portfolio and ranking #14 among its reported holdings. RIVERBRIDGE PARTNERS LLC has disclosed WST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)208.01K sh
Reported value held$77.12M
Portfolio Weight2.26%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How RIVERBRIDGE PARTNERS LLC's WST position evolved

RIVERBRIDGE PARTNERS LLC first disclosed a stake in WST in Q3 2023 at 524,019 shares (US$196.6M). The position peaked in Q1 2024 at 501,891 shares, worth US$198.6M. Across 13 filings, RIVERBRIDGE PARTNERS LLC increased the stake 0 time(s), trimmed it 12 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 208,015 shares valued at US$77.1M — a reduction of -24,499 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 524.02K $196.62M New
Q4 2023 516.02K $181.70M Reduce
Q1 2024 501.89K $198.60M Reduce
Q2 2024 486.94K $160.39M Reduce
Q3 2024 456.75K $137.10M Reduce
Q4 2024 435.29K $142.58M Reduce
Q1 2025 408.41K $91.43M Reduce
Q2 2025 383.52K $83.91M Reduce
Q3 2025 362.54K $95.11M Reduce
Q4 2025 318.61K $87.66M Reduce
Q1 2026 261.44K $65.53M Reduce
Q2 2026 232.51K $83.47M Reduce
Q3 2026 208.01K $77.12M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 28 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$744.4M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has RIVERBRIDGE PARTNERS LLC held WST?

RIVERBRIDGE PARTNERS LLC has disclosed WST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is RIVERBRIDGE PARTNERS LLC's current position in WST?

As of Q3 2026, RIVERBRIDGE PARTNERS LLC holds 208.01K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $77.12M, representing 2.26% of its reported portfolio and ranking #14.

Has RIVERBRIDGE PARTNERS LLC been buying or selling WST?

In the latest 13F filing (Q3 2026), RIVERBRIDGE PARTNERS LLC reduced its position in WST. The position peaked in Q1 2024 at 501.89K shares.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.